Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XERS | LYRA | AKBA | ||
| Company | Xeris Pharmaceuticals Inc | Lyra Therapeutics Inc | Akebia Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.9000 | 4.66 | 1.3400 | ||
| High | 1.9300 | 4.71 | 1.4200 | ||
| Low | 1.8400 | 3.92 | 1.3200 | ||
| Last | 1.8900 | 4.03 | 1.3850 | ||
| Change | +0.0300 | -0.60 | +0.0850 | ||
| % Change | +1.61% | -12.96% | +6.54% | ||
| Volume | 942,441 | 2,249,139 | 2,716,451 | ||
| 20-Day Average Volume | 1,273,056 | 370,680 | 3,108,287 | ||
| Previous Close | 1.8600 | 4.63 | 1.3000 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8318 | 5.12 | 1.3915 | ||
| 20-Day Raw Stochastic | 46.67% | 6.76% | 43.21% | ||
| 20-Day Relative Strength | 41.97% | 33.82% | 46.09% | ||
| Weighted Alpha | -19.67 | +9.68 | +4.79 | ||
| Today's Opinion | 40% Sell | 24% Sell | 8% Buy | ||
| Previous Opinion | 40% Sell | 8% Buy | 24% Sell | ||
| Last Month's Opinion | 40% Sell | 64% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.57% since 04/26/24 | -14.30% since 04/26/24 | +3.73% since 04/26/24 | ||
| Low | 1.7100 on 04/29/24 | 3.92 on 05/03/24 | 1.2150 on 05/02/24 | ||
| High | 1.9300 on 05/03/24 | 5.65 on 05/01/24 | 1.4200 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -10.34% since 04/03/24 | -25.92% since 04/03/24 | -6.71% since 04/03/24 | ||
| Low | 1.6900 on 04/26/24 | 3.92 on 05/03/24 | 1.2150 on 05/02/24 | ||
| High | 2.1100 on 04/04/24 | 5.77 on 04/17/24 | 1.6200 on 04/10/24 | ||
| 3-Month | |||||
| %Chg | -23.88% since 02/02/24 | -13.57% since 02/02/24 | -15.76% since 02/02/24 | ||
| Low | 1.6900 on 04/26/24 | 3.92 on 05/03/24 | 1.2150 on 05/02/24 | ||
| High | 3.2600 on 02/15/24 | 6.79 on 03/27/24 | 2.4800 on 03/28/24 | ||
| 6-Month | |||||
| %Chg | -1.84% since 11/03/23 | +29.65% since 11/03/23 | +47.11% since 11/03/23 | ||
| Low | 1.4600 on 11/15/23 | 2.50 on 11/09/23 | 0.8800 on 11/13/23 | ||
| High | 3.2600 on 02/15/24 | 6.79 on 03/27/24 | 2.4800 on 03/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 275,752 | 282,268 | 272,184 | ||
| Shares Outstanding, K | 148,254 | 60,965 | 209,372 | ||
| Annual Sales | 163,910,000 | 1,560,000 | 194,620,000 | ||
| Annual Net Income | -62,260,000 | -62,680,000 | -51,930,000 | ||
| Last Quarter Sales | 44,390,000 | 150,000 | 56,070,000 | ||
| Last Quarter Net Income | -13,390,000 | -15,160,000 | -50,000 | ||
| 60-Month Beta | 2.37 | 0.31 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 03/06/24 | -0.35 on 04/30/24 | 0.00 on 03/14/24 | ||
| Latest Earnings Date | 05/14/24 | 05/10/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||